Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation.
Limited quarterly history available
EPS needs at least three reported quarters before a meaningful chart is shown.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Mobia Medical, Inc. Common Stock
Market Cap
$308.22M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$301.07M
Earnings Per Share (EPS)
-0.98
TTM Avg
-1.02
3Y Avg
-4.71
5Y Avg
-10.90
Market Cap
$320.64M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.40
3Y Avg
-2.02
5Y Avg
-1.91
Market Cap
$295.55M
Earnings Per Share (EPS)
-1.99
TTM Avg
-1.79
3Y Avg
-1.44
5Y Avg
-2.04
Market Cap
$321.44M
Earnings Per Share (EPS)
-1.45
TTM Avg
-2.06
3Y Avg
-1.65
5Y Avg
-1.47
Market Cap
$322.92M
Earnings Per Share (EPS)
-0.63
TTM Avg
-0.48
3Y Avg
-0.42
5Y Avg
-0.42
Market Cap
$290.39M
Earnings Per Share (EPS)
N/A
TTM Avg
-2880.36
3Y Avg
-1920.24
5Y Avg
-1440.18
Market Cap
$327.34M
Earnings Per Share (EPS)
-1.18
TTM Avg
-0.80
3Y Avg
-0.80
5Y Avg
-0.72
Market Cap
$288.38M
Earnings Per Share (EPS)
-1.11
TTM Avg
-0.10
3Y Avg
-2.07
5Y Avg
-8.75
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $308.22M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $301.07M | -0.98 | -1.02 | -4.71 | -10.90 |
| C4 Therapeutics, Inc. (CCCC)vs › | $320.64M | -1.00 | -1.40 | -2.02 | -1.91 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $295.55M | -1.99 | -1.79 | -1.44 | -2.04 |
| Avita Medical Inc. (RCEL)vs › | $321.44M | -1.45 | -2.06 | -1.65 | -1.47 |
| CapsoVision, Inc. (CV)vs › | $322.92M | -0.63 | -0.48 | -0.42 | -0.42 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.39M | N/A | -2880.36 | -1920.24 | -1440.18 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $327.34M | -1.18 | -0.80 | -0.80 | -0.72 |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.38M | -1.11 | -0.10 | -2.07 | -8.75 |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.33M | -1.28 | -1.52 | -1.49 | -1.26 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-2.95
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.02 |
